Allogene Therapeutics, Inc. (ALLO)
2.39
+0.02
(+0.84%)
USD |
NASDAQ |
Apr 17, 16:00
2.33
-0.06
(-2.51%)
After-Hours: 05:21
Allogene Therapeutics SG&A Expense (Quarterly) : 13.77M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 82.79M |
| Agenus, Inc. | 12.30M |
| Inovio Pharmaceuticals, Inc. | 7.215M |
| Vaxart, Inc. | 3.666M |
| Capricor Therapeutics, Inc. | 6.025M |